Literature DB >> 7316992

Calcitonin binding and degradation by two cultured human breast cancer cell lines (MCF 7 and T 47D).

D M Findlay, V P Michelangeli, J M Moseley, T J Martin.   

Abstract

Two human breast cancer cell lines (MCF 7 and T 47D) possess calcitonin-responsive adenylate cyclase systems. Suspended cells of both lines specifically bound 125I-labelled salmon calcitonin with mean dissociation constants of 1.7 nM (MCF 7) and 1.4 nM (T 47D); mean receptor numbers were 5300 and 24400 per cell respectively. Measurement of specific binding to MCF 7 cells was obscured by rapid and substantial degradation of the labelled hormone. Degradation of 125I-labelled salmon calcitonin: (i) was of high capacity; (ii) lacked the specificity displayed by 125I-labelled salmon calcitonin binding to the same cells; and (iii) was not related to binding since cell incubation supernatants retained full degrading activity. The degrading activity was inhibited by corticotropin (1-24)-tetracosapeptide, insulin and bacitracin. Inclusion of bacitracin in the incubation resulted in apparently fewer numbers of lower affinity receptors on MCF 7 cells, whereas these parameters were identical to T 47D cells incubated in the presence or absence of bacitracin. Eel [2-aminosuberic acid 1,7]-calcitonin was resistant to proteolysis in the presence of either cell line. Analysis of hormone-receptor interactions with calcitonin-responsive cells should take account of potent calcitonin-degrading activities in some cell lines.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7316992      PMCID: PMC1163024          DOI: 10.1042/bj1960513

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

Review 1.  Calcitonin binding sites in bone: relationships to biological response and "escape".

Authors:  A H Tashjian; D R Wright; J L Ivey; A Pont
Journal:  Recent Prog Horm Res       Date:  1978

2.  Calcitonin and calcium ionophores: cyclic AMP responses in cells of a human lymphoid line.

Authors:  J Moran; W Hunziker; J A Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Inhibitors of glucagon inactivation. Effect on glucagon--receptor interactions and glucagon-stimulated adenylate cyclase activity in liver cell membranes.

Authors:  B Desbuquois; F Krug; P Cuatrecasas
Journal:  Biochim Biophys Acta       Date:  1974-03-20

4.  Determination of protein: a modification of the Lowry method that gives a linear photometric response.

Authors:  E F Hartree
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

5.  Preparation and characterization of a hormone-responsive renal plasma membrane fraction.

Authors:  S J Marx; S A Fedak; G D Aurbach
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

6.  Renal receptors for calcitonin. Binding and degradation of hormone.

Authors:  S J Marx; C Woodward; G D Aurbach; H Glossmann; H T Keutmann
Journal:  J Biol Chem       Date:  1973-07-10       Impact factor: 5.157

7.  Calcitonin receptors of kidney and bone.

Authors:  S J Marx; C J Woodward; G D Aurbach
Journal:  Science       Date:  1972-12-01       Impact factor: 47.728

8.  Analogues of human calcitonin. II. Influence of modifications in amino acid positions 1, 8 and 22 on hypocalcemic activity in the rat.

Authors:  R Maier; B Kamber; B Riniker; W Rittel
Journal:  Horm Metab Res       Date:  1975-11       Impact factor: 2.936

9.  Steroid receptor analyses of nine human breast cancer cell lines.

Authors:  K B Horwitz; D T Zava; A K Thilagar; E M Jensen; W L McGuire
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

10.  Effect of guanyl nucleotides on parathyroid hormone-responsive adenylate cyclase in chick kidney.

Authors:  N H Hunt; T J Martin; V P Michelangeli; J A Eisman
Journal:  J Endocrinol       Date:  1976-06       Impact factor: 4.286

View more
  7 in total

Review 1.  Peptides from the calcitonin genes: molecular genetics, structure and function.

Authors:  L H Breimer; I MacIntyre; M Zaidi
Journal:  Biochem J       Date:  1988-10-15       Impact factor: 3.857

2.  Solubilization of functional calcitonin receptors.

Authors:  G C Nicholson; C S D'Santos; T Evans; J M Moseley; B E Kemp; T J Martin
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

3.  Cloning, characterization, and expression of a human calcitonin receptor from an ovarian carcinoma cell line.

Authors:  A H Gorn; H Y Lin; M Yamin; P E Auron; M R Flannery; D R Tapp; C A Manning; H F Lodish; S M Krane; S R Goldring
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

4.  Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.

Authors:  S Takahashi; S Goldring; M Katz; S Hilsenbeck; R Williams; G D Roodman
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

5.  Characteristics of selective activation of cyclic AMP-dependent protein kinase isoenzymes by calcitonin and prostaglandin E2 in human breast cancer cells.

Authors:  S A Livesey; G Collier; J D Zajac; B E Kemp; T J Martin
Journal:  Biochem J       Date:  1984-12-01       Impact factor: 3.857

6.  Human placental calcitonin receptors.

Authors:  G C Nicholson; C S D'Santos; T Evans; J M Moseley; B E Kemp; V P Michelangeli; T J Martin
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

7.  Calcitonin receptor expression in medullary thyroid carcinoma.

Authors:  Virginia Cappagli; Catarina Soares Potes; Luciana Bueno Ferreira; Catarina Tavares; Catarina Eloy; Rossella Elisei; Manuel Sobrinho-Simões; Peter J Wookey; Paula Soares
Journal:  PeerJ       Date:  2017-09-13       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.